October 11, 2024 9:53 am
The Department of Transportation has made it clear that the potential rescheduling of marijuana will not alter truck driver drug testing requirements.
The Department of Transportation (DOT) has made it clear that the potential rescheduling of marijuana will not alter truck driver drug testing requirements. This clarification came directly from Transportation Secretary Pete Buttigieg during a House committee hearing on June 27.
In May, the Department of Justice (DOJ) proposed reclassifying marijuana from a Schedule I to a Schedule III drug. This shift sparked concern within the trucking industry, as many feared it might affect truck driver drug testing protocols. However, Secretary Buttigieg reassured that this change would not impact the DOT’s authority or procedures regarding marijuana testing.
“Any impaired driving – be it alcohol, marijuana, or any other source of impairment – is, of course, a major safety concern,” Buttigieg stated. He emphasized that the rescheduling of marijuana would not alter DOT’s testing requirements since marijuana is identified by name in drug testing regulations, not by its classification schedule.
The American Trucking Associations (ATA) quickly responded to the DOJ’s proposal, expressing their concerns in letters to Secretary Buttigieg. They sought confirmation that the DOT would maintain its ability to test for marijuana use among commercial drivers and other safety-sensitive transportation workers. In response, Buttigieg reiterated that the DOT’s commitment to drug testing remains unchanged, regardless of marijuana’s scheduling status.
The public has been given until July 22 to comment on the DOJ’s proposal, and as of June 27, over 25,000 comments had been submitted. Despite the feedback period, Buttigieg made it clear that the DOT has no plans to modify its truck driver drug testing policies concerning marijuana. “Our commitment to that testing continues regardless of the schedule, and we believe our authorities are intact,” he said.
Currently, marijuana is a Schedule I drug, categorized alongside substances like heroin and LSD, which are considered to have no accepted medical use and a high potential for abuse. As a Schedule III drug, marijuana would be classified with substances that have a moderate to low potential for physical and psychological dependence, such as low doses of codeine and testosterone.
Despite the reclassification, recreational marijuana remains legal in 24 states. However, it remains off-limits for commercial vehicle drivers, irrespective of the state they live in or travel through. This stance is due to the significant safety risks associated with impaired driving. Statistics show that from 2000 to 2018, crash deaths involving marijuana more than doubled, from 9% to 21.5%.
Chris Spear, President and CEO of the ATA, expressed gratitude towards Congressman Rick Crawford for addressing this critical issue during the hearing. Spear emphasized the importance of continued drug testing to prevent impaired drivers from jeopardizing road safety. He noted that the trucking industry and DOT share the goal of achieving zero highway fatalities and ensuring that commercial drivers are qualified to operate vehicles safely.
Aside from the marijuana reclassification topic, the hearing also addressed the ongoing issue of truck parking. Representative Mike Bost expressed disappointment that the DOT budget did not include specific funds for creating truck parking spaces. Secretary Buttigieg responded by highlighting the administration’s efforts to encourage states to allocate available funds for truck parking projects. He mentioned funded projects in states like Wyoming, Tennessee, and Florida as examples of ongoing support for truck drivers.
The DOT’s stance on marijuana testing remains firm despite the DOJ’s proposal to reclassify the drug. Truck drivers and other safety-sensitive transportation workers will continue to be subject to stringent truck driver drug testing requirements, ensuring that road safety is not compromised. As the public comment period continues, industry stakeholders will closely monitor any developments that may impact these policies.